Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Indacaterol Glycopyrronium ×

Indacaterol Glycopyrronium

This drug is selected. Its supporting articles are shown below.

Indacaterol Glycopyrronium1

Articles mentioning Indacaterol Glycopyrronium

1 articles · page 1 of 1

Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial

thoraxjnl · abstract · 2026-05-14 · 1 matching annotations

92.9%

Indacaterol Glycopyrronium Fluticasone Salmeterol LABA LAMA COPD chronic obstructive pulmonary disease NCT01782326

…med a post hoc analysis of the 52-week, double-blind, Effect of Indacaterol Glycopyrronium versus Fluticasone Salmeterol on COPD Exacerbations trial that …

Browse drugs

Indacaterol Glycopyrronium

Articles mentioning Indacaterol Glycopyrronium

Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial